| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |